Side-effects of inotuzumab ozogamicin
Next steps for Hodgkin lymphoma - combining brentuximab vedotin with checkpoint inhibitors
Predicting and diagnosing TB and CMV in hematopoietic cell transplant recipients
Why has the biobank project been a success and what is the future for it?
Regis Peffault de Latour
Big data on efficacy and toxicity levels for ibrutinib in CLL